Literature DB >> 23335742

In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.

Sarah S Gonçalves1, Alberto M Stchigel, Josep Cano, Josep Guarro, Arnaldo L Colombo.   

Abstract

The in vitro antifungal susceptibility of 77 isolates belonging to different clinically relevant species of Aspergillus section Flavi, including those of different phylogenetic clades of A. flavus, was tested for nine antifungal agents using a microdilution reference method (CLSI, M38-A2). Terbinafine and the echinocandins demonstrated lower MICs/MECs for all species evaluated, followed by posaconazole. Amphotericin B showed MICs ≥ 2 μg/ml for 38 (49.4%) of the 77 isolates tested.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23335742      PMCID： PMC3623352          DOI： 10.1128/AAC.01902-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

1.  The phylogenetics of mycotoxin and sclerotium production in Aspergillus flavus and Aspergillus oryzae.

Authors:  D M Geiser; J W Dorner; B W Horn; J W Taylor
Journal:  Fungal Genet Biol       Date:  2000-12       Impact factor: 3.495

Review 2.  Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.

Authors:  I Stratov; T M Korman; P D R Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-07       Impact factor: 3.267

3.  Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

Authors:  J Morgan; K A Wannemuehler; K A Marr; S Hadley; D P Kontoyiannis; T J Walsh; S K Fridkin; P G Pappas; D W Warnock
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

4.  Onychomycosis due to Aspergillus tamarii in a 3-year-old boy.

Authors:  Lise Kristensen; Jørgen Stenderup; Aksel Otkjaer
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

5.  Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation.

Authors:  J Guinea; T Peláez; L Alcalá; M J Ruiz-Serrano; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 6.  [Invasive nasosinusal aspergillosis in an immunocompetent patient].

Authors:  G Paludetti; M Rosignoli; E Ferri; M R Cesari; G Morace; M Fantoni; J Galli
Journal:  Acta Otorhinolaryngol Ital       Date:  1992 Nov-Dec       Impact factor: 2.124

7.  Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species.

Authors:  Felix Gilgado; Josep Cano; Josepa Gené; Josep Guarro
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

8.  In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.

Authors:  Alicia Gomez-Lopez; Guillermo Garcia-Effron; Emilia Mellado; Araceli Monzon; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

Authors:  C Lass-Flörl; G Kofler; G Kropshofer; J Hermans; A Kreczy; M P Dierich; D Niederwieser
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

10.  Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae.

Authors:  K Akiyama; H Takizawa; M Suzuki; S Miyachi; M Ichinohe; Y Yanagihara
Journal:  Chest       Date:  1987-02       Impact factor: 9.410
View more
  16 in total

1.  Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.

Authors:  Cheshta Sharma; Rakesh Kumar; Nitin Kumar; Aradhana Masih; Dinesh Gupta; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.

Authors:  Mojtaba Taghizadeh-Armaki; Mohammad Taghi Hedayati; Saham Ansari; Saeed Mahdavi Omran; Sasan Saber; Haleh Rafati; Jan Zoll; Henrich A van der Lee; Willem J G Melchers; Paul E Verweij; Seyedmojtaba Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

3.  Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis.

Authors:  Shivaprakash M Rudramurthy; Seyedmojtaba Seyedmousavi; Manpreet Dhaliwal; Arunaloke Chakrabarti; Jacques F Meis; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

4.  Aspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditions.

Authors:  Jesús Guinea; Marcelo Sandoval-Denis; Pilar Escribano; Teresa Peláez; Josep Guarro; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

5.  Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020).

Authors:  Cecilia G Carvalhaes; Abby L Klauer; Paul R Rhomberg; Michael A Pfaller; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2022-03-07       Impact factor: 11.677

6.  Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.

Authors:  Elif Erdem; Meltem Yagmur; Hazal Boral; Macit Ilkit; Reha Ersoz; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2016-11-08       Impact factor: 2.574

7.  Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.

Authors:  Clara E Negri; Sarah S Gonçalves; Ana Cristina P Sousa; Maria Daniela Bergamasco; Marinês D V Martino; Flavio Queiroz-Telles; Valerio Rodrigues Aquino; Paulo de Tarso O Castro; Ferry Hagen; Jacques F Meis; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

8.  Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.

Authors:  C E Negri; S S Gonçalves; H Xafranski; M D Bergamasco; V R Aquino; P T O Castro; A L Colombo
Journal:  J Clin Microbiol       Date:  2014-07-30       Impact factor: 5.948

9.  Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of Aspergillus spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species.

Authors:  Anna Rozaliyani; Asriyani Abdullah; Findra Setianingrum; Wellyzar Sjamsuridzal; Retno Wahyuningsih; Anom Bowolaksono; Ayu Eka Fatril; Robiatul Adawiyah; Mulyati Tugiran; Ridhawati Syam; Heri Wibowo; Chris Kosmidis; David W Denning
Journal:  J Fungi (Basel)       Date:  2022-04-16

Review 10.  Global Aspects of Triazole Resistance in Aspergillus fumigatus with Focus on Latin American Countries.

Authors:  Sarah Santos Gonçalves
Journal:  J Fungi (Basel)       Date:  2017-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.